BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of 2.84 billion. The enterprise value is 2.62 billion.

Market Cap	2.84B
Enterprise Value	2.62B

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.32M
Shares Outstanding	n/a
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	31.95%
Owned by Institutions (%)	50.09%
Float	54.61M

Valuation Ratios

The trailing PE ratio is 25.64 and the forward PE ratio is 118.84.

PE Ratio	25.64
Forward PE	118.84
PS Ratio	13.11
PB Ratio	13.33
P/TBV Ratio	13.33
P/FCF Ratio	n/a
P/OCF Ratio	18.32
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	23.59
EV / Sales	12.35
EV / EBITDA	n/a
EV / EBIT	17.83
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.02.

Current Ratio	4.78
Quick Ratio	4.21
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	36.52

Financial Efficiency

Return on equity (ROE) is 71.44% and return on invested capital (ROIC) is 58.45%.

Return on Equity (ROE)	71.44%
Return on Assets (ROA)	46.93%
Return on Invested Capital (ROIC)	58.45%
Return on Capital Employed (ROCE)	67.38%
Weighted Average Cost of Capital (WACC)	-0.61%
Revenue Per Employee	1.66M
Profits Per Employee	846,673
Employee Count	131
Asset Turnover	1.08
Inventory Turnover	n/a

Taxes

In the past 12 months, BioArctic AB has paid 25.31 million in taxes.

Income Tax	25.31M
Effective Tax Rate	18.58%

Stock Price Statistics

The stock price has increased by +45.46% in the last 52 weeks. The beta is -0.91, so BioArctic AB's price volatility has been lower than the market average.

Beta (5Y)	-0.91
52-Week Price Change	+45.46%
50-Day Moving Average	26.83
200-Day Moving Average	21.34
Relative Strength Index (RSI)	51.51
Average Volume (20 Days)	426

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of 216.89 million and earned 110.91 million in profits. Earnings per share was 1.25.

Revenue	216.89M
Gross Profit	210.46M
Operating Income	150.19M
Pretax Income	136.22M
Net Income	110.91M
EBITDA	n/a
EBIT	150.19M
Earnings Per Share (EPS)	1.25

Full Income Statement

Balance Sheet

The company has 237.64 million in cash and 4.78 million in debt, with a net cash position of 232.86 million.

Cash & Cash Equivalents	237.64M
Total Debt	4.78M
Net Cash	232.86M
Net Cash Per Share	n/a
Equity (Book Value)	213.41M
Book Value Per Share	2.41
Working Capital	213.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	155.26M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 97.04%, with operating and profit margins of 69.25% and 51.14%.

Gross Margin	97.04%
Operating Margin	69.25%
Pretax Margin	62.81%
Profit Margin	51.14%
EBITDA Margin	n/a
EBIT Margin	69.25%
FCF Margin	n/a

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	-0.25%
Earnings Yield	3.90%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6